Combined stratification of refractory anemia according to both WHO and IPSS criteria improves identification of patients who may benefit from stem cell transplantation. Retrospective analysis of 197 patients with primary myelodysplastic syndrome

Abstract

Refractory anemia, stem cell transplatation